Zyla Life Sciences Proceeds from Stock Options Exercised
Zyla Life Sciences reported Proceeds from Stock Options Exercised of $82.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2015-11-06
- Zyla Life Sciences proceeds from stock options exercised for the quarter ending 2015-09-30 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $82.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $82.00K 10-Q · filed 2015-08-07 |